Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Jiun Su

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 11, 2022
Pretreatment frailty is an independent prognostic factor among elderly patients with B-cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in TaiwanYu-Shin Hung, Hung Chang, Po-Nan Wang, et al.
Healthcare (Basel, Switzerland)|November 27, 2021
Bone Marrow Hypocellularity in Patients with End-Stage Kidney DiseaseChia-Chen Hsieh, Ming-Jen Chan, Yi-Jiun Su, et al.
Clinical and Experimental Medicine|September 7, 2023
Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in TaiwanChin-Hsuan Chuang, Ming-Chung Kuo, Hung Chang, et al.
European Journal of Haematology|June 17, 2018
Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 casesYi-Jiun Su, Po-Nan Wang, Hung Chang, et al.
European Journal of Haematology|May 31, 2020
Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapyWen-Chi Chou, Hung Chang, Po-Nan Wang, et al.
Clinical and Experimental Medicine|April 22, 2023
Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphomaNing-Chun Chen, Hung Chang, Hsiao-Wen Kao, et al.
Blood Advances|January 31, 2024
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphomaEsther H Nie, Yi-Jiun Su, John H Baird, et al.
Annals of Medicine|March 20, 2025
Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomasChu-Yi Chan, Tung-Liang Lin, Ming-Chung Kuo, et al.
Cancer Science|July 23, 2022
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemiaYi-Jiun Su, Ming-Chung Kuo, Tsai-Yun Chen, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Asia-Pacific Journal of Clinical Oncology|April 11, 2022
Pretreatment frailty is an independent prognostic factor among elderly patients with B-cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in TaiwanYu-Shin Hung, Hung Chang, Po-Nan Wang, et al.
Healthcare (Basel, Switzerland)|November 27, 2021
Bone Marrow Hypocellularity in Patients with End-Stage Kidney DiseaseChia-Chen Hsieh, Ming-Jen Chan, Yi-Jiun Su, et al.
Clinical and Experimental Medicine|September 7, 2023
Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in TaiwanChin-Hsuan Chuang, Ming-Chung Kuo, Hung Chang, et al.
European Journal of Haematology|June 17, 2018
Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 casesYi-Jiun Su, Po-Nan Wang, Hung Chang, et al.
European Journal of Haematology|May 31, 2020
Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapyWen-Chi Chou, Hung Chang, Po-Nan Wang, et al.
Clinical and Experimental Medicine|April 22, 2023
Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphomaNing-Chun Chen, Hung Chang, Hsiao-Wen Kao, et al.
Blood Advances|January 31, 2024
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphomaEsther H Nie, Yi-Jiun Su, John H Baird, et al.
Annals of Medicine|March 20, 2025
Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomasChu-Yi Chan, Tung-Liang Lin, Ming-Chung Kuo, et al.
Cancer Science|July 23, 2022
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemiaYi-Jiun Su, Ming-Chung Kuo, Tsai-Yun Chen, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Pageof 3